Purdue Pharma, US states agree to new opioid settlement
OxyContin maker Purdue Pharma reached a settlement over its role in the nation’s deadly opioid crisis that includes all U.S. states and thousands of local governments, with the Sackler family
Stay updated with breaking news from Ed Bisch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OxyContin maker Purdue Pharma reached a settlement over its role in the nation’s deadly opioid crisis that includes all U.S. states and thousands of local governments, with the Sackler family
Washington will receive an additional $113 million from Purdue Pharma and the Sackler family as part of a new settlement reached Thursday with the OxcyContin maker over its role in the nation’s deadly opioid crisis.
The deal follows an earlier settlement that had been appealed by eight states and the District of Columbia.
The new plan was hammered out with attorneys general from the eight states and D.C. who had opposed the earlier one, arguing that it did not properly hold Sackler family members accountable.
Purdue Pharma reached a nationwide settlement Thursday over its role in the opioid crisis, with the Sackler family members who own the company boosting their cash contribution to as much as $6 billion in a deal intended to staunch a flood of lawsuits facing the maker of OxyContin.